N. Caporaso

4.4k total citations
107 papers, 2.6k citations indexed

About

N. Caporaso is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, N. Caporaso has authored 107 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Epidemiology, 53 papers in Hepatology and 17 papers in Genetics. Recurrent topics in N. Caporaso's work include Liver Disease Diagnosis and Treatment (50 papers), Hepatitis C virus research (43 papers) and Hepatitis B Virus Studies (22 papers). N. Caporaso is often cited by papers focused on Liver Disease Diagnosis and Treatment (50 papers), Hepatitis C virus research (43 papers) and Hepatitis B Virus Studies (22 papers). N. Caporaso collaborates with scholars based in Italy, Russia and United States. N. Caporaso's co-authors include Filomena Morisco, Paola Vitaglione, Vincenzo Fogliano, Antonio Rispo, Nicola Imperatore, Raffaella Tortora, Maria Guarino, Concetta Tuccillo, Giuseppe D’Argenio and G. Mazzone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

N. Caporaso

106 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Caporaso Italy 28 1.2k 878 366 328 319 107 2.6k
C. Del Vecchio Blanco Italy 28 1.1k 0.9× 691 0.8× 146 0.4× 784 2.4× 656 2.1× 71 2.6k
Veysel Tahan United States 33 1.0k 0.8× 857 1.0× 109 0.3× 707 2.2× 531 1.7× 164 3.0k
J. Christian Bode Germany 26 947 0.8× 321 0.4× 168 0.5× 348 1.1× 651 2.0× 60 2.5k
Christiane Bode Germany 25 889 0.7× 294 0.3× 133 0.4× 254 0.8× 760 2.4× 49 2.5k
İbrahim Halil Bahçecioğlu Türkiye 25 847 0.7× 391 0.4× 95 0.3× 281 0.9× 259 0.8× 71 1.6k
Filomena Morisco Italy 33 2.0k 1.7× 1.6k 1.8× 80 0.2× 264 0.8× 558 1.7× 166 3.8k
Halina Cichoż‐Lach Poland 18 659 0.5× 328 0.4× 138 0.4× 289 0.9× 500 1.6× 84 1.9k
Jae Seok Hwang South Korea 27 975 0.8× 758 0.9× 241 0.7× 650 2.0× 572 1.8× 121 2.6k
Marcello Dallio Italy 29 1.6k 1.3× 506 0.6× 103 0.3× 357 1.1× 903 2.8× 98 3.2k
Shahram Agah Iran 28 499 0.4× 174 0.2× 279 0.8× 501 1.5× 683 2.1× 135 2.4k

Countries citing papers authored by N. Caporaso

Since Specialization
Citations

This map shows the geographic impact of N. Caporaso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Caporaso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Caporaso more than expected).

Fields of papers citing papers by N. Caporaso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Caporaso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Caporaso. The network helps show where N. Caporaso may publish in the future.

Co-authorship network of co-authors of N. Caporaso

This figure shows the co-authorship network connecting the top 25 collaborators of N. Caporaso. A scholar is included among the top collaborators of N. Caporaso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Caporaso. N. Caporaso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvaro, Domenico, N. Caporaso, Edoardo G. Giannini, et al.. (2021). Procedure‐related bleeding risk in patients with cirrhosis and severe thrombocytopenia. European Journal of Clinical Investigation. 51(6). e13508–e13508. 27 indexed citations
2.
Sabbatini, Massimo, Ivana Capuano, Silvia Camera, et al.. (2018). Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life. BioMed Research International. 2018. 1–7. 6 indexed citations
3.
Guarino, Maria, et al.. (2018). Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows. World Journal of Gastroenterology. 24(24). 2582–2595. 57 indexed citations
4.
Morisco, Filomena, Tommaso Stroffolini, Flavia Lombardo, et al.. (2017). Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination. Digestive and Liver Disease. 49(11). 1257–1261. 11 indexed citations
5.
Morisco, Filomena, Ilaria Loperto, Tommaso Stroffolini, et al.. (2016). Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades. Journal of Medical Virology. 89(2). 291–297. 42 indexed citations
6.
Rispo, Antonio, Nicola Imperatore, Anna Testa, et al.. (2016). Bowel Damage in Crohnʼs Disease. Inflammatory Bowel Diseases. 23(1). 143–151. 39 indexed citations
8.
Costanzo, G.G. Di, Raffaella Tortora, Filomena Morisco, et al.. (2016). Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma. Targeted Oncology. 12(1). 61–67. 18 indexed citations
9.
Testa, Anna, Antonio Rispo, Marco Romano, et al.. (2015). The burden of anaemia in patients with inflammatory bowel diseases. Digestive and Liver Disease. 48(3). 267–270. 18 indexed citations
10.
Morisco, Filomena, Vincenzo Lembo, G. Mazzone, Silvia Camera, & N. Caporaso. (2014). Coffee and Liver Health. Journal of Clinical Gastroenterology. 48(Supplement 1). S87–S90. 25 indexed citations
11.
Morisco, Filomena, Eugenio Aprea, Vincenzo Lembo, et al.. (2013). Rapid “Breath-Print” of Liver Cirrhosis by Proton Transfer Reaction Time-of-Flight Mass Spectrometry. A Pilot Study.. PLoS ONE. 8(4). e59658–e59658. 62 indexed citations
12.
Morisco, Filomena, L. Pagliaro, N. Caporaso, et al.. (2008). Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels. Digestive and Liver Disease. 40(7). 585–598. 17 indexed citations
13.
Vitaglione, Paola, et al.. (2006). Development of a tomato-based food for special medical purposes as therapy adjuvant for patients with HCV infection. European Journal of Clinical Nutrition. 61(7). 906–915. 19 indexed citations
14.
Carella, Carlo, Gherardo Mazziotti, Filomena Morisco, et al.. (2001). Long-Term Outcome of Interferon-α-Induced Thyroid Autoimmunity and Prognostic Influence of Thyroid Autoantibody Pattern at the End of Treatment. The Journal of Clinical Endocrinology & Metabolism. 86(5). 1925–1929. 77 indexed citations
15.
Morisco, Filomena, et al.. (2000). Subjects positive for hepatitis C virus RNA with normal aminotransferase levels, a “trompe l'oeil” clinical picture?. Digestive and Liver Disease. 32(7). 598–602. 1 indexed citations
16.
Caporaso, N., G. Del Vecchio Blanco, Concetta Tuccillo, et al.. (1997). HCV infection in symptom-free patients. Research in Virology. 148(2). 123–125. 2 indexed citations
17.
Carella, Carlo, Giovanni Amato, Bernadette Biondi, et al.. (1995). Longitudinal Study of Antibodies against Thyroid in Patients Undergoing Interferon-α Therapy for HCV Chronic Hepatitis. Hormone Research. 44(3). 110–114. 61 indexed citations
18.
Caporaso, N., Marco Romano, Riccardo Marmo, et al.. (1991). Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. Journal of Hepatology. 12(3). 367–371. 67 indexed citations
19.
Farci, Patrizia, C. Barbera, Flavia Bortolotti, et al.. (1985). Infection with the delta agent in children.. Gut. 26(1). 4–7. 27 indexed citations
20.
Lavarini, C, Patrizia Farci, E. Chiaberge, et al.. (1983). IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis.. BMJ. 287(6401). 1254–1256. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026